Consensus statement calls for robust outcome measures for coeliac treatments

An expert panel has made recommendations to strengthen assessment of potential new treatments for coeliac disease. With a confusing array of histology, serology, immunological markers and patient-reported outcomes being used in clinical trials of novel coeliac treatments, an international taskforce has investigated which are the most appropriate. The Tampere recommendations acknowledge the increasing number of ...

Already a member?

Login to keep reading.

© 2021 the limbic